2021
DOI: 10.1016/j.csbj.2021.07.039
|View full text |Cite
|
Sign up to set email alerts
|

Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 52 publications
1
22
0
Order By: Relevance
“…, combretastatin A4), and insufficient potency ( e.g. , verubulin), colchicine-binding site agents have not been approved for cancer therapy so far ( 12 ). Thus, developing novel, safe, and highly efficacious colchicine-binding site agents to treat NSCLC is of paramount urgency.…”
mentioning
confidence: 99%
“…, combretastatin A4), and insufficient potency ( e.g. , verubulin), colchicine-binding site agents have not been approved for cancer therapy so far ( 12 ). Thus, developing novel, safe, and highly efficacious colchicine-binding site agents to treat NSCLC is of paramount urgency.…”
mentioning
confidence: 99%
“…Molecular docking studies predict the PILA9 binds to the colchicine site of tubulin, which likely underlies the microtubule alterations observed after treatment with this compound. The binding mode of PILA9 to the colchicine site of tubulin is like those of the MDS and to the experimentally determined binding modes of other colchicine site ligands such as the combretastatin A4 or colchicine [ 9 ], thus suggesting a common mechanism of action mediated by tubulin binding.…”
Section: Discussionmentioning
confidence: 77%
“…The carbonyl group of the carbamoyl group hydrogen bonds to the backbone NH of Val181α, in a similar way as the hydroxyl group of combretastatin A4 or the ketone of the tropolone of colchicine, while the amino group hydrogen bonds to the backbone carbonyl of Asn349β. The similar binding modes to the colchicine site of tubulin of PILA9 , the MDS, and combretastatin A4 or colchicine [ 9 ] suggest a common mechanism of action mediated by tubulin binding.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations